Triple negative breast cancer (TNBC) is an aggressive form of breast cancer that is negative for estrogen, progesterone, and human epidermal growth factor (HER2) receptors…
Triple-negative breast cancer (TNBC) presents considerable therapeutic challenges due to disease heterogeneity, absence of established therapeutic targets, and aggressive metastatic potential with higher rate of distant recurrence…
For many years now, transition metal complexes have been used as favorable additional chemotherapeutic approaches to medicine that were previously unexplored in the literature…
Triple negative breast cancer (TNBC) presents one of the most aggressive and difficult to treat breast cancer subtypes as these cancer cells lack three receptors: estrogen, progesterone, and human epidermal growth factor receptor 2…
It is a worrying fact that chemotherapeutic options for treating triple negative breast cancer are limited in nature, including cisplatin, which has been reported to have various side effects during chemotherapeutic treatment on the patient…
Medulloblastoma (MB) is characterized as a grade IV embryonal brain tumor that primarily affects children. Standard treatments for medulloblastoma include radiation and chemotherapeutic agents…